Therapeutic Asset Ratings
176 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Atx-295
Triple-Negative Breast Carcinoma
Accent Therapeutics
P1
C
(37)
Azirkitug
Triple-Negative Breast Carcinoma
AbbVie
P1
C
(37)
Bdc-3042
Triple-Negative Breast Carcinoma
Bolt Biotherapeutics, Inc.
P1
C
(37)
Biological Ni-1801
Triple-Negative Breast Carcinoma
Light Chain Bioscience - Novimmune SA
P1
C
(37)
Budigalimab
Triple-Negative Breast Carcinoma
AbbVie
P1
C
(37)
Bulumtatug Fuvedotin
Triple-Negative Breast Carcinoma
Mabwell (Shanghai) Bioscience Co., Ltd.
P1
C
(37)
Cid-078 Monotherapy
Triple-Negative Breast Carcinoma
Circle Pharma
P1
C
(37)
CRX100
Triple-Negative Breast Carcinoma
BioEclipse Therapeutics
P1
C
(37)
Ctx-8371
Triple-Negative Breast Carcinoma
Compass Therapeutics
P1
C
(37)
DARATUMUMAB
Triple-Negative Breast Carcinoma
Andrew Hantel, MD
P1
C
(37)
dky709
Triple-Negative Breast Carcinoma
Novartis Pharmaceuticals
P1
C
(37)
dr-0202
Triple-Negative Breast Carcinoma
Dren Bio
P1
C
(37)
Etakafusp Alfa
Triple-Negative Breast Carcinoma
Washington University School of Medicine
P1
C
(37)
Evorpacept
Triple-Negative Breast Carcinoma
QuantumLeap Healthcare Collaborative
P1
C
(37)
Fam-Trastuzumab Deruxtecan-Nxki
Triple-Negative Breast Carcinoma
QuantumLeap Healthcare Collaborative
P1
C
(37)
Gcar1
Triple-Negative Breast Carcinoma
Canadian Cancer Trials Group
P1
C
(37)
her2 - primed dendritic cells
Triple-Negative Breast Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
P1
C
(37)
her3 - primed dendritic cells
Triple-Negative Breast Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
P1
C
(37)
hh160
Triple-Negative Breast Carcinoma
Huahui Health
P1
C
(37)
ic9-car.b7-h3 t cell therapy
Triple-Negative Breast Carcinoma
UNC Lineberger Comprehensive Cancer Center
P1
C
(37)
ide034
Triple-Negative Breast Carcinoma
IDEAYA Biosciences
P1
C
(37)
Itc-6146Ro
Triple-Negative Breast Carcinoma
IntoCell, Inc
P1
C
(37)
Itraconazole
Triple-Negative Breast Carcinoma
Eli Lilly and Company
P1
C
(37)
ly4052031
Triple-Negative Breast Carcinoma
Eli Lilly and Company
P1
C
(37)
ly4101174
Triple-Negative Breast Carcinoma
Eli Lilly and Company
P1
C
(37)
Showing 126 to 150 of 176 assets
Previous
Page 6 of 8
Next